BlackRock »

Royalty Pharma shares owned by BlackRock

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $631M 22M 28.29

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Royalty Pharma

Morgan Stanley
Vanguard Group
BlackRock
BlackRock
Baillie Gifford & Co
Viking Global Investors
Swedbank AB
State Street Corporation
Geode Capital Management
Unisphere Establishment
Amundi
Siguler Guff Advisers
Charles Schwab Investment Management
Northern Trust
New South Capital Management

View all funds holding Royalty Pharma